July 01, 2013 at 11:30 AM EDT
Five Star Equities Issues New Research Reports on ACI, AMED, DNDN and RENN

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

Arch Coal Inc. (NYSE: ACI) shares spiked 5.0 percent to close at $3.78 a share Friday. The stock traded between $3.64 and $3.90 on volume of 14.25 million shares traded. The company announced it has agreed to divest its non-core Utah operations to Bowie Resources for $435 million in cash. Shares of Arch Coal have fallen approximately 48.4 percent year-to-date.

Get more information on Arch Coal and free access to the in-depth equity report at: www.FiveStarEquities.com/ACI

Amedisys Inc. (NASDAQ: AMED) shares declined 12.69 percent to close at $11.60 a share Friday. The stock traded between $9.51 and $12.15 on volume of 3.13 million shares traded. Shares of home health-care stocks fell sharply after the Centers for Medicare & Medicaid Services proposed a rate cut of 3.5 percent per year over the next four years. Shares of Amedisys are up approximately 2.6 percent year-to-date.

Get more information on Amedisys and free access to the in-depth equity report at: www.FiveStarEquities.com/AMED

Dendreon Corporation (NASDAQ: DNDN) shares increased 0.98 percent to close at $4.12 a share Friday. The stock traded between $4.12 and $4.49 on volume of 12.40 million shares traded. The company announced that it has received a positive opinion for PROVENGE from the European Medicines Agency Committee for Medicinal Products for Human Use. Shares of Dendreon have fallen approximately 22.1 percent year-to-date.

Get more information on Dendreon and free access to the in-depth equity report at: www.FiveStarEquities.com/DNDN

Renren Inc. (NYSE: RENN) shares jumped 5.28 percent to close at $2.99 a share Friday. The stock traded between $2.88 and $3.04 on volume of 2.89 million shares traded. The company’s Board of Directors has authorized a new $100 million share repurchase program. Shares of Renren have fallen approximately 13.3 percent year-to-date.

Get more information on Renren and free access to the in-depth equity report at: www.FiveStarEquities.com/RENN

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact: Five Star Equities info@fivestarequities.com

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here